Cara Therapeutics Inc (DELISTED) (CARA:DL)
17.04
-1.21
(-6.63%)
USD |
NASDAQ |
Apr 17, 16:00
Cara Therapeutics Profit Margin (Quarterly): -527.8% for Dec. 31, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| TG Therapeutics, Inc. | -- |
| ADMA Biologics, Inc. | 27.14% |
| Ocular Therapeutix, Inc. | -477.3% |
| Ocugen, Inc. | -1.14K% |
| Editas Medicine, Inc. | -333.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -374.6% |
| Return on Assets | -92.37% |
| Return on Invested Capital | -374.6% |
| Operating Margin (Quarterly) | -381.2% |
| Return on Net Operating Assets | -505.5% |